Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expanding the role of proteasome homeostasis in Parkinson’s disease: beyond protein breakdown
Mingxia Bi, Xixun Du, Qian Jiao, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids
Dieter Willbold, Birgit Strodel, Gunnar F. Schröder, et al.
Chemical Reviews (2021) Vol. 121, Iss. 13, pp. 8285-8307
Open Access | Times Cited: 152
Heat Shock Response and Heat Shock Proteins: Current Understanding and Future Opportunities in Human Diseases
Manish Singh, Yoonhwa Shin, Songhyun Ju, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4209-4209
Open Access | Times Cited: 39
Evolving Landscape of Parkinson’s Disease Research: Challenges and Perspectives
Rumiana Koynova, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Omega (2025) Vol. 10, Iss. 2, pp. 1864-1892
Open Access | Times Cited: 2
Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics
Amrita Kulkarni, Preeti Kumari, Kamatham Pushpa Tryphena, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101816-101816
Closed Access | Times Cited: 39
Single-nucleus multi-omics of Parkinson’s disease reveals a glutamatergic neuronal subtype susceptible to gene dysregulation via alteration of transcriptional networks
E. Keats Shwab, Daniel Gingerich, Zhaohui Man, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Probiotic lactic acid bacteria promote anti-tumor immunity through enhanced major histocompatibility complex class I-restricted antigen presentation machinery in dendritic cells
Suguru Saito, Alato Okuno, Zhenzi Peng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Regulation of Inflammatory Cell Death by Phosphorylation
Wen Xu, Yi Huang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Modulating the Ubiquitin–Proteasome System: A Therapeutic Strategy for Autoimmune Diseases
Dhananjay Yadav, Ji Yeon Lee, Nidhi Puranik, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1093-1093
Open Access | Times Cited: 23
Deficient immunoproteasome assembly drives gain of α-synuclein pathology in Parkinson's disease
Mingxia Bi, Xixun Du, Xue Xiao, et al.
Redox Biology (2021) Vol. 47, pp. 102167-102167
Open Access | Times Cited: 27
α-Synuclein pathology as a target in neurodegenerative diseases
Hye-Jin Park, Tae‐In Kam, Valina L. Dawson, et al.
Nature Reviews Neurology (2024)
Closed Access | Times Cited: 4
Chemical and Biological Mechanisms Relevant to the Rescue of MG-132-Treated Neurons by Cysteine
Anna‐Katharina Ückert, Ilinca Suciu, Anja Land, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 128-128
Open Access
The Role of ΔFosB in the Pathogenesis of Levodopa-Induced Dyskinesia: Mechanisms and Therapeutic Strategies
Mohammad Yasin Zamanian, Zahra Kamran, Marziye Ranjbar Tavakoli, et al.
Molecular Neurobiology (2025)
Closed Access
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease
Taylor R. Church, Seth S. Margolis
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Patient-centered brain transcriptomic and multimodal imaging determinants of clinical progression, physical activity, and treatment needs in Parkinson’s disease
Quadri Adewale, Ahmed Faraz Khan, Sue‐Jin Lin, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery
Milo Jarno Basellini, Josine Marie Kothuis, Alessandro Comincini, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 2, pp. 33-33
Open Access | Times Cited: 10
CNS-Related Effects Caused by Vanadium at Realistic Exposure Levels in Humans: A Comprehensive Overview Supplemented with Selected Animal Studies
Agnieszka Ścibior, Juan Llopis, Paweł Dobrakowski, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9004-9004
Open Access | Times Cited: 10
New molecular mechanisms to explain the neuroprotective effects of insulin-like growth factor II in a cellular model of Parkinson’s disease
Silvana Y. Romero‐Zerbo, Nadia Valverde, Silvia Claros, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 3
Genetics of Parkinson's disease: Dominant forms and GBA
Philippe A. Salles, José M. Tirapegui, Pedro Chaná‐Cuevas
Neurology Perspectives (2024) Vol. 4, Iss. 3, pp. 100153-100153
Open Access | Times Cited: 3
Midnolin, a Genetic Risk Factor for Parkinson’s Disease, Promotes Neurite Outgrowth Accompanied by Early Growth Response 1 Activation in PC12 Cells
Ayano Chiba, Chisato Kato, Tadashi Nakagawa, et al.
Molecular and Cellular Biology (2024), pp. 1-12
Open Access | Times Cited: 3
UBA52 Is Crucial in HSP90 Ubiquitylation and Neurodegenerative Signaling during Early Phase of Parkinson’s Disease
Shubhangini Tiwari, Abhishek Singh, Parul Gupta, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3770-3770
Open Access | Times Cited: 14
Network Analysis Performed on Transcriptomes of Parkinson’s Disease Patients Reveals Dysfunction in Protein Translation
Simone D’Angiolini, Maria Lui, Emanuela Mazzon, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1299-1299
Open Access | Times Cited: 2
Early deficits in an in vitro striatal microcircuit model carrying the Parkinson’s GBA-N370S mutation
Quyen Do, Humaira Noor, Ricardo Márquez-Gómez, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
PSMF1variants cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality by disrupting mitochondrial pathways
Francesca Magrinelli, Christelle Tesson, Plamena R. Angelova, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Discovery of novel VEGFR-2-PROTAC degraders based on the localization of lysine residues via recruiting VHL for the treatment of gastric cancer
Xingrong Wang, Shuai Wang, Hong-Xia Mu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114821-114821
Closed Access | Times Cited: 11
Implications of intracellular protein degradation pathways in Parkinson's disease and therapeutics
K Amrutha, Amit Mishra, Sarika Singh
Journal of Neuroscience Research (2022) Vol. 100, Iss. 10, pp. 1834-1844
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top